Ken Griffin Inogen Inc Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Inogen Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 16,900 shares of INGN stock, worth $137,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,900
Previous 1,400
1107.14%
Holding current value
$137,397
Previous $7,000
1842.86%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding INGN
# of Institutions
138Shares Held
21.8MCall Options Held
252KPut Options Held
183K-
Camber Capital Management LP Boston, MA2MShares$16.3 Million0.4% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.98MShares$16.1 Million0.29% of portfolio
-
Black Rock Inc. New York, NY1.67MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$11.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.28MShares$10.4 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $186M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...